Bisphosphonates: Enhancing Bone Health in Metastatic Prostate Cancer Management
Reading Time: 2 minutes Introduction to Prostate Cancer and Bone Health Prostate cancer remains a significant health concern for American men, with the American Cancer Society estimating over 268,000 new cases in 2023 alone. As the disease progresses, it often metastasizes to the bones, leading to complications such as pain, fractures, and hypercalcemia. This progression underscores the importance of managing bone health in men with advanced prostate cancer. Bisphosphonates, a class of drugs primarily used to treat osteoporosis, have emerged as a crucial tool in mitigating the skeletal-related events associated with metastatic prostate cancer. Understanding Bisphosphonates Bisphosphonates work by inhibiting osteoclast activity, the cells...



